ImmunologybioRxivPreprint
Efineptakin alfa (NT-I7) improves overall survival and induces tertiary lymphoid structures in murine lung tumors
Trang Dinh, Judong Lee, Sidra Islam…·Rebecca C. Obeng
This study shows efineptakin alfa (NT-I7) improves survival and induces tertiary lymphoid structures in murine lung tumors, potentially enhancing immunotherapy efficacy.
DOI 10.1101/2025.09.15.676444